The global demand for Bioresorbable Medical Material Market is presumed to reach the market size of nearly USD 4352.27 Million by 2032 from USD 1871.66 Million in 2023 with a CAGR of 9.83% under the study period 2024-2032.
Bioresorbable medical materials are designed to be absorbed and eliminated by the body after fulfilling their intended function. These materials are commonly used in medical implants, sutures, and drug delivery systems. Manufactured from polymers such as polylactic acid (PLA) or polyglycolic acid (PGA), bioresorbable materials gradually break down into natural byproducts like water and carbon dioxide, which are safely absorbed or excreted by the body. The primary advantage of these materials is that they eliminate the need for a second surgery to remove implants, reducing the risk of complications and enhancing patient recovery.
The increasing demand for minimally invasive surgeries benefits from bioresorbable medical materials like sutures, stents, and screws. These materials eliminate the necessity for subsequent surgery to remove implants, lowering patient risks and healthcare expenses. Technological advancements, such as improved polymers and biocompatibility, enhance their performance and expand their applications. The rising burden of chronic diseases such as cardiovascular diseases and orthopedic injuries contributes significantly to market expansion. Furthermore, the expanding geriatric population, which is more prone to fractures and other medical ailments, further drives market growth. Government initiatives and funding for research and development in biomedical materials further support market growth. Increased awareness and acceptance among healthcare professionals and patients regarding the benefits of bioresorbable medical materials, such as reduced long-term complications and enhanced healing, also drive the market. Moreover, the push for environmentally sustainable medical solutions boosts the adoption of bioresorbable medical materials, as they minimize the ecological footprint compared to traditional non-degradable materials. However, the constrained availability of raw materials and the high costs associated with production could pose challenges to market growth in the foreseeable future.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioresorbable Medical Material. The growth and trends of Bioresorbable Medical Material industry provide a holistic approach to this study.
This section of the Bioresorbable Medical Material market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
This section covers the regional outlook, which accentuates current and future demand for the Bioresorbable Medical Material market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioresorbable Medical Material market include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1. PREFACE
1.1. Report Description
1.1.1 Objective
1.1.2 Target Audience
1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1 Market Research Process
1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. BIORESORBABLE MEDICAL MATERIAL – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL BIORESORBABLE MEDICAL MATERIAL MARKET ANALYSIS BY TYPE
5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Polylactic Acid (PLA) Historic and Forecast Sales By Regions
5.4. Polyglycolic Acid (PGA) Historic and Forecast Sales By Regions
5.5. Polysaccharides Historic and Forecast Sales By Regions
5.6. Polycaprolactone (PCL) Historic and Forecast Sales By Regions
5.7. PLGA Historic and Forecast Sales By Regions
6. GLOBAL BIORESORBABLE MEDICAL MATERIAL MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug Delivery Historic and Forecast Sales By Regions
6.4. Orthopedics Historic and Forecast Sales By Regions
7. GLOBAL BIORESORBABLE MEDICAL MATERIAL MARKET ANALYSIS BY G...
